Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $1,377,673 (100.0% shares, 0.0% debt)

Holdings (9)

MRNA Moderna Inc 72.5%

Value ($000) $998,405 Shares 9,666,038 Est. Cost $16.43 Unrealized +578.8%

SANA Sana Biotechnology Inc 7.0%

Value ($000) $96,757 Shares 25,001,856 Est. Cost $32.56 Unrealized -83.5%

FHTX Foghorn Therapeutics Inc 4.6%

Value ($000) $63,371 Shares 12,674,120 Est. Cost $19.16 Unrealized -59.8%

— Omega Therapeutics Inc 4.6%

Value ($000) $62,835 Shares 29,225,579 Est. Cost $17.39 Unrealized —

— Seres Therapeutics Inc 4.0%

Value ($000) $55,019 Shares 23,117,045 Est. Cost $7.75 Unrealized —

DNLI Denali Therapeutics Inc 3.9%

Value ($000) $54,050 Shares 2,619,968 Est. Cost $17.97 Unrealized +41.1%

EVLO Evelo Biosciences Inc 2.3%

Value ($000) $31,096 Shares 7,932,624 Est. Cost $5.60 Unrealized +21.9%

— Axcella Health Inc 0.9%

Value ($000) $12,215 Shares 1,170,059 Est. Cost $10.44 Unrealized —

SYRS Syros Pharmaceuticals Inc 0.3%

Value ($000) $3,926 Shares 993,848 Est. Cost $8.12 Unrealized -53.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MRNA	Moderna Inc	9,666,038	$998,405	72.5%	$16.43	+578.8%	COM	60770K107
SANA	Sana Biotechnology Inc	25,001,856	$96,757	7.0%	$32.56	-83.5%	COM	799566104
FHTX	Foghorn Therapeutics Inc	12,674,120	$63,371	4.6%	$19.16	-59.8%	COM	344174107
—	Omega Therapeutics Inc	29,225,579	$62,835	4.6%	$17.39	—	COM	68217N105
—	Seres Therapeutics Inc	23,117,045	$55,019	4.0%	$7.75	—	COM	81750R102
DNLI	Denali Therapeutics Inc	2,619,968	$54,050	3.9%	$17.97	+41.1%	COM	24823R105
EVLO	Evelo Biosciences Inc	7,932,624	$31,096	2.3%	$5.60	+21.9%	COM	299734202
—	Axcella Health Inc	1,170,059	$12,215	0.9%	$10.44	—	COM	05454B204
SYRS	Syros Pharmaceuticals Inc	993,848	$3,926	0.3%	$8.12	-53.9%	COM	87184Q206